Call us 24/7
303-981-3117
Main Menu
Category Menu
Contact Details
- +1-(978) 251-1206
- Gearperformance@mail.com
- 23 Lovett Ln North Chelmsford, Massachusetts(MA), 01863
End of Content.
Call us 24/7
+08 9229 8228
303-981-3117
End of Content.
+08 9229 8228
In Stock
Retatrutide is an investigational once-weekly triple-hormone receptor agonist (targeting GIP, GLP-1, and glucagon receptors) developed by Eli Lilly, showing unprecedented weight loss results in trials, with up to ~24% body weight reduction in 48 weeks. Currently in Phase 3 trials (TRIUMPH program), it is designed for obesity, type 2 diabetes, and related conditions, with potential FDA approval expected around summer 2026
Retatrutide is an investigational once-weekly triple-hormone receptor agonist (targeting GIP, GLP-1, and glucagon receptors) developed by Eli Lilly, showing unprecedented weight loss results in trials, with up to ~24% body weight reduction in 48 weeks. Currently in Phase 3 trials (TRIUMPH program), it is designed for obesity, type 2 diabetes, and related conditions, with potential FDA approval expected around summer 2026
Reviews
There are no reviews yet.